18654 Federal Register / Vol. 80, No. 66 / Tuesday, April 7, 2015 / Notices 

hearing (even in instances in which the 

participant, or its counsel or 

representative, already holds an NRCissued digital ID certificate). Based upon 

this information, the Secretary will 

establish an electronic docket for the 

hearing in this proceeding if the 

Secretary has not already established an 

electronic docket. 

Information about applying for a 

digital ID certificate is available on 

NRC’s public Web site at http://www.

nrc.gov/site-help/e-submittals/applycertificates.html. System requirements 

for accessing the E-Submittal server are 

detailed in NRC’s ‘‘Guidance for 

Electronic Submission,’’ which is 

available on the agency’s public Web 

site at http://www.nrc.gov/site-help/esubmittals.html. Participants may 

attempt to use other software not listed 

on the Web site, but should note that the 

NRC’s E-Filing system does not support 

unlisted software, and the NRC Meta 

System Help Desk will not be able to 

offer assistance in using unlisted 

software. 

If a participant is electronically 

submitting a document to the NRC in 

accordance with the E-Filing rule, the 

participant must file the document 

using the NRC’s online, web-based 

submission form. In order to serve 

documents through Electronic 

Information Exchange (EIE), users will 

be required to install a web browser 

plug-in from the NRC Web site. Further 

information on the web-based 

submission form, including the 

installation of the Web browser plug-in, 

is available on the NRC’s public Web 

site at http://www.nrc.gov/site-help/esubmittals.html. 

Once a participant has obtained a 

digital ID certificate and a docket has 

been created, the participant can then 

submit a request for hearing or petition 

for leave to intervene through the EIE. 

Submissions should be in Portable 

Document Format (PDF) in accordance 

with NRC guidance available on the 

NRC public Web site at http://www.nrc.

gov/site-help/e-submittals.html. A filing 

is considered complete at the time the 

documents are submitted through the 

NRC’s E-Filing system. To be timely, an 

electronic filing must be submitted to 

the E-Filing system no later than 11:59 

p.m. Eastern Time (ET) on the due date. 

Upon receipt of a transmission, the EFiling system time-stamps the document 

and sends the submitter an email notice 

confirming receipt of the document. The 

E-Filing system also distributes an email 

notice that provides access to the 

document to the NRC Office of the 

General Counsel and any others who 

have advised the Office of the Secretary 

that they wish to participate in the 

proceeding, so that the filer need not 

serve the documents on those 

participants separately. Therefore, any 

others who wish to participate in the 

proceeding (or their counsel or 

representative) must apply for and 

receive a digital ID certificate before a 

hearing request/petition to intervene is 

filed so that they can obtain access to 

the document via the E-Filing system. 

A person filing electronically using 

the agency’s adjudicatory E-Filing 

system may seek assistance by 

contacting the NRC Meta System Help 

Desk through the ‘‘Contact Us’’ link 

located on the NRC Web site at http:// 

www.nrc.gov/site-help/esubmittals.html, by email at 

MSHD.Resource@nrc.gov, or by a tollfree call at (866) 672–7640. The NRC 

Meta System Help Desk is available 

between 8 a.m. and 8 p.m., ET, Monday 

through Friday, excluding government 

holidays. 

Participants who believe that they 

have a good cause for not submitting 

documents electronically must file an 

exemption request, in accordance with 

10 CFR 2.302(g), with their initial paper 

filing requesting authorization to 

continue to submit documents in paper 

format. Such filings must be submitted 

by: (1) First class mail addressed to the 

Office of the Secretary of the 

Commission, U.S. Nuclear Regulatory 

Commission, Washington, DC 20555– 

0001, Attention: Rulemaking and 

Adjudications Staff; or (2) courier, 

express mail, or expedited delivery 

service to the Office of the Secretary, 

Sixteenth Floor, One White Flint North, 

11555 Rockville Pike, Rockville, 

Maryland, 20852, Attention: 

Rulemaking and Adjudications Staff. 

Participants filing a document in this 

manner are responsible for serving the 

document on all other participants. 

Filing is considered complete by firstclass mail as of the time of deposit in 

the mail, or by courier, express mail, or 

expedited delivery service upon 

depositing the document with the 

provider of the service. A presiding 

officer, having granted an exemption 

request from using E-Filing, may require 

a participant or party to use E-Filing if 

the presiding officer subsequently 

determines that the reason for granting 

the exemption from use of E-Filing no 

longer exists. 

Documents submitted in adjudicatory 

proceedings will appear in NRC’s 

electronic hearing docket, which is 

available to the public at http://

ehd1.nrc.gov/ehd/, unless excluded 

pursuant to an order of the Commission, 

or the presiding officer. Participants are 

requested not to include personal 

privacy information, such as social 

security numbers, home addresses, or 

home phone numbers in their filings, 

unless an NRC regulation or other law 

requires submission of such 

information. With respect to 

copyrighted works, except for limited 

excerpts that serve the purpose of the 

adjudicatory filings and would 

constitute a Fair Use application, 

participants are requested not to include 

copyrighted materials in their 

submission. 

If a person other than the Licensee 

requests a hearing, that person shall set 

forth with particularity the manner in 

which his interest is adversely affected 

by this Order and shall address the 

criteria set forth in 10 CFR 2.309(d) and 

(f). 

If a hearing is requested by the 

Licensee or a person whose interest is 

adversely affected, the Commission will 

issue an Order designating the time and 

place of any hearing. If a hearing is held, 

the issue to be considered at such 

hearing shall be whether this Order 

should be sustained. In the absence of 

any request for a hearing, or written 

approval of an extension of time in 

which to request a hearing, the 

provisions specified in Section IV above 

shall be final 30 days from the date this 

Order is issued without further order or 

proceedings. If an extension of time for 

requesting a hearing has been approved, 

the provisions specified in Section IV 

shall be final when the extension 

expires if a hearing request has not been 

received. If payment has not been made 

by the time specified above, the matter 

may be referred to the Attorney General 

for collection. [light face signature 

below] 

Dated this 27th day of March, 2015. 

For the Nuclear Regulatory Commission 

Darrell J. Roberts 

Acting Regional Administrator Region III 

[FR Doc. 2015–07984 Filed 4–6–15; 8:45 am] 

BILLING CODE CODE 7590–01–P 

NUCLEAR REGULATORY 

COMMISSION 

Advisory Committee on the Medical 

Uses of Isotopes; Call for Nominations 

AGENCY: U.S. Nuclear Regulatory 

Commission. 

ACTION: Call for Nominations. 

SUMMARY: The U.S. Nuclear Regulatory 

Commission (NRC) is advertising for 

nominations for the position of Nuclear 

Pharmacist on the Advisory Committee 

on the Medical Uses of Isotopes 

(ACMUI). Nominees should be a 

currently practicing nuclear pharmacist. 

mstockstill on DSK4VPTVN1PROD with NOTICES

Federal Register / Vol. 80, No. 66 / Tuesday, April 7, 2015 / Notices 18655 

DATES: Nominations are due on or 

before June 8, 2015. 

NOMINATION PROCESS: Submit an 

electronic copy of resume or curriculum 

vitae to Ms. Sophie Holiday, 

Sophie.Holiday@nrc.gov. Please ensure 

that the resume or curriculum vitae 

includes the following information, if 

applicable: Education; certification; 

professional association membership 

and committee membership activities; 

duties and responsibilities in current 

and previous clinical, research, and/or 

academic position(s). 

FOR FURTHER INFORMATION CONTACT: Ms. 

Sophie Holiday, U.S. Nuclear 

Regulatory Commission, Office of 

Nuclear Material Safety and Safeguards; 

telephone (404) 997–4691; email: 

Sophie.Holiday@nrc.gov. 

SUPPLEMENTARY INFORMATION: The 

ACMUI Nuclear Pharmacist provides 

advice on issues associated with the 

regulation of nuclear pharmacy 

applications of byproduct material. This 

advice includes providing input on NRC 

proposed rules and guidance, providing 

recommendations on the training and 

experience requirements for Authorized 

Nuclear Pharmacists, identifying 

medical events associated with these 

uses, evaluating non-routine uses of 

byproduct material, bringing key issues 

in the nuclear pharmacy community to 

the attention of NRC staff, as they relate 

to radiopharmaceuticals, radiation 

safety and NRC medical-use policy. 

ACMUI members are selected based 

on their educational background, 

certification(s), work experience, 

involvement and/or leadership in 

professional society activities, and other 

information obtained in letters or during 

the selection process. 

ACMUI members possess the medical 

and technical skills needed to address 

evolving issues. The current 

membership is comprised of the 

following professionals: (a) Nuclear 

medicine physician; (b) nuclear 

cardiologist; (c) two radiation 

oncologists; (d) diagnostic radiologist; 

(e) therapy medical physicist; (f) nuclear 

medicine physicist; (g) nuclear 

pharmacist; (h) health care 

administrator; (i) radiation safety officer; 

(j) patients’ rights advocate; (k) Food 

and Drug Administration representative; 

and (l) Agreement State representative. 

NRC is inviting nominations for the 

Nuclear Pharmacist to the ACMUI. The 

term of the individual currently 

occupying this position will end March 

29, 2016. Committee members currently 

serve a four-year term and may be 

considered for reappointment to an 

additional term. 

Nominees must be U.S. citizens and 

be able to devote approximately 160 

hours per year to Committee business. 

Members who are not Federal 

employees are compensated for their 

service. In addition, members are 

reimbursed for travel (including perdiem in lieu of subsistence) and are 

reimbursed secretarial and 

correspondence expenses. Full-time 

Federal employees are reimbursed travel 

expenses only. 

Security Background Check: The 

selected nominee will undergo a 

thorough security background check. 

Security paperwork may take the 

nominee several weeks to complete. 

Nominees will also be required to 

complete a financial disclosure 

statement to avoid conflicts of interest. 

Dated at Rockville, Maryland, this 1st day 

of April, 2015. 

For the U.S. Nuclear Regulatory 

Commission. 

Andrew L. Bates, 

Advisory Committee Management Officer. 

[FR Doc. 2015–07993 Filed 4–6–15; 8:45 am] 

BILLING CODE CODE 7590–01–P 

NUCLEAR REGULATORY 

COMMISSION 

Advisory Committee on the Medical 

Uses of Isotopes: Meeting Notice 

AGENCY: U.S. Nuclear Regulatory 

Commission. 

ACTION: Notice of meeting. 

SUMMARY: The U.S. Nuclear Regulatory 

Commission will convene a 

teleconference meeting of the Advisory 

Committee on the Medical Uses of 

Isotopes (ACMUI) on June 16, 2015, to 

discuss the ACMUI Radioactive Seed 

Localization subcommittee report and to 

hear a presentation from Spectrum 

Pharmaceuticals regarding the training 

and experience requirements for alpha 

and beta emitters. Meeting information, 

including a copy of the agenda and 

handouts, will be available at http://

www.nrc.gov/reading-rm/doccollections/acmui/meetings/2015.html. 

The agenda and handouts may also be 

obtained by contacting Ms. Sophie 

Holiday using the information below. 

DATES: The teleconference meeting will 

be held on Tuesday, June 16, 2015, 2:00 

p.m. to 5:00 p.m. Eastern Standard 

Time. 

Public Participation: Any member of 

the public who wishes to participate in 

the teleconference should contact Ms. 

Holiday using the contact information 

below. 

FOR FURTHER INFORMATION CONTACT: Ms. 

Sophie Holiday, U.S. Nuclear 

Regulatory Commission, Office of 

Nuclear Material Safety and Safeguards; 

telephone: (404) 997–4691, email: 

sophie.holiday@nrc.gov. 

Conduct of the Meeting 

Dr. Bruce Thomadsen, ACMUI 

Chairman, will preside over the 

meeting. Dr. Thomadsen will conduct 

the meeting in a manner that will 

facilitate the orderly conduct of 

business. The following procedures 

apply to public participation in the 

meeting: 

1. Persons who wish to provide a 

written statement should submit an 

electronic copy to Ms. Holiday at the 

contact information listed above. All 

submittals must be received by June 11, 

2015, three business days prior to the 

meeting, and must pertain to the topic 

on the agenda for the meeting. 

2. Questions and comments from 

members of the public will be permitted 

during the meetings, at the discretion of 

the Chairman. 

3. The draft transcript and meeting 

summary will be available on ACMUI’s 

Web site http://www.nrc.gov/readingrm/doc-collections/acmui/meetings/

2015.html on or about July 29, 2015. 

This meeting will be held in 

accordance with the Atomic Energy Act 

of 1954, as amended (primarily Section 

161a); the Federal Advisory Committee 

Act (5 U.S.C. App); and the 

Commission’s regulations in Title 10 of 

the Code of Federal Regulations Part 7. 

Dated at Rockville, Maryland, this 1st day 

of April, 2015. 

For the U.S. Nuclear Regulatory 

Commission. 

Andrew L. Bates, 

Advisory Committee Management Officer. 

[FR Doc. 2015–07990 Filed 4–6–15; 8:45 am] 

BILLING CODE CODE 7590–01–P 

NUCLEAR REGULATORY 

COMMISSION 

[NRC–2015–0058] 

Applications and Amendments to 

Facility Operating Licenses and 

Combined Licenses Involving 

Proposed No Significant Hazards 

Considerations and Containing 

Sensitive Unclassified Non-Safeguards 

Information and Order Imposing 

Procedures for Access to Sensitive 

Unclassified Non-Safeguards 

Information 

AGENCY: Nuclear Regulatory 

Commission. 

ACTION: License amendment request; 

opportunity to comment, request a 

mstockstill on DSK4VPTVN1PROD with NOTICES